{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:05:56Z","timestamp":1780484756540,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01982-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:27:39Z","timestamp":1767954459000},"page":"2131-2143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural Assessment of Fibrillated Beta Amyloid to Reveal the Potential Epitopes for Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"84","author":[{"given":"Hwanhee","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1982_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12031-021-01824-8","volume":"72","author":"P Girotra","year":"2022","unstructured":"Girotra, P., Behl, T., Sehgal, A., Singh, S., & Bungau, S. (2022). Investigation of the molecular role of Brain-Derived neurotrophic factor in alzheimer\u2019s disease. Journal of Molecular Neuroscience, 72, 173\u2013186. https:\/\/doi.org\/10.1007\/s12031-021-01824-8","journal-title":"Journal of Molecular Neuroscience"},{"key":"1982_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G Chen","year":"2017","unstructured":"Chen, G., Xu, T., Yan, Y., Zhou, Y., Jiang, Y., Melcher, K., & Xu, H. E. (2017). Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacologica Sinica, 38, 1205\u20131235. https:\/\/doi.org\/10.1038\/aps.2017.28","journal-title":"Acta Pharmacologica Sinica"},{"key":"1982_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023). Amyloid \u03b2-based therapy for alzheimer\u2019s disease: challenges, successes and future. Signal Transduction and Targeted Therapy, 8, 248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1982_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky, R., Jessen, F., Grimmer, T., Levin, J., Fl\u00f6el, A., Peters, O., & Froelich, L. (2023). Anti-amyloid antibody therapies in alzheimer\u2019s disease. Brain, 146, 842\u2013849. https:\/\/doi.org\/10.1093\/brain\/awad005","journal-title":"Brain"},{"key":"1982_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A., & Higgins, G. A. (1992). Alzheimer\u2019s disease: The amyloid cascade hypothesis. Science, 256, 184\u2013185. https:\/\/doi.org\/10.1126\/science.1566067","journal-title":"Science"},{"key":"1982_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992). Amyloid \u03b2-peptide is produced by cultured cells during normal metabolism. Nature, 359, 322\u2013325. https:\/\/doi.org\/10.1038\/359322a0","journal-title":"Nature"},{"key":"1982_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1023\/b:nere.0000014834.06405.af","volume":"29","author":"L Canevari","year":"2004","unstructured":"Canevari, L., Abramov, A. Y., & Duchen, M. R. (2004). Toxicity of amyloid beta peptide: Tales of calcium, mitochondria, and oxidative stress. Neurochemical Research, 29, 637\u2013650. https:\/\/doi.org\/10.1023\/b:nere.0000014834.06405.af","journal-title":"Neurochemical Research"},{"key":"1982_CR8","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.3390\/ijms26136271","volume":"26","author":"HM Yang","year":"2025","unstructured":"Yang, H. M. (2025). Recent advances in antibody therapy for alzheimer\u2019s disease: Focus on bispecific antibodies. International Journal of Molecular Sciences, 26, 6271.","journal-title":"International Journal of Molecular Sciences"},{"key":"1982_CR9","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/wnl.0000000000001017","volume":"83","author":"K Endres","year":"2014","unstructured":"Endres, K., Fahrenholz, F., Lotz, J., Hiemke, C., Teipel, S., Lieb, K., T\u00fcscher, O., & Fellgiebel, A. (2014). Increased CSF APPs-\u03b1 levels in patients with alzheimer disease treated with acitretin. Neurology, 83, 1930\u20131935. https:\/\/doi.org\/10.1212\/wnl.0000000000001017","journal-title":"Neurology"},{"key":"1982_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/oajct.s221914","volume":"12","author":"B Decourt","year":"2020","unstructured":"Decourt, B., Wilson, J., Ritter, A., Dardis, C., DiFilippo, F. P., Zhuang, X., Cordes, D., Lee, G., Fulkerson, N. D., St Rose, T., et al. (2020). MCLENA-1: A phase II clinical trial for the assessment of Safety, Tolerability, and efficacy of Lenalidomide in patients with mild cognitive impairment due to alzheimer\u2019s disease. Open Access J Clin Trials, 12, 1\u201313. https:\/\/doi.org\/10.2147\/oajct.s221914","journal-title":"Open Access J Clin Trials"},{"key":"1982_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","volume":"7","author":"A Bakker","year":"2015","unstructured":"Bakker, A., Albert, M. S., Krauss, G., Speck, C. L., & Gallagher, M. (2015). Response of the medial Temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance. Neuroimage Clin, 7, 688\u2013698. https:\/\/doi.org\/10.1016\/j.nicl.2015.02.009","journal-title":"Neuroimage Clin"},{"key":"1982_CR12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/jnnp-2012-302589","volume":"83","author":"ML Maccecchini","year":"2012","unstructured":"Maccecchini, M. L., Chang, M. Y., Pan, C., John, V., Zetterberg, H., & Greig, N. H. (2012). Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: Target engagement, tolerability and pharmacokinetics in humans. Journal of Neurology, Neurosurgery and Psychiatry, 83, 894\u2013902. https:\/\/doi.org\/10.1136\/jnnp-2012-302589","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"1982_CR13","doi-asserted-by":"publisher","unstructured":"Cummings, J. L., Zhong, K., Kinney, J. W., Heaney, C., Moll-Tudla, J., Joshi, A., Pontecorvo, M., Devous, M., Tang, A., & Bena, J. (2016). Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer\u2019s disease. Alzheimer\u2019S Research & Therapy, 8(4). https:\/\/doi.org\/10.1186\/s13195-016-0173-2","DOI":"10.1186\/s13195-016-0173-2"},{"key":"1982_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","volume":"57","author":"JA Hey","year":"2018","unstructured":"Hey, J. A., Yu, J. Y., Versavel, M., Abushakra, S., Kocis, P., Power, A., Kaplan, P. L., Amedio, J., & Tolar, M. (2018). Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of Tramiprosate in development for the treatment of alzheimer\u2019s disease. Clinical Pharmacokinetics, 57, 315\u2013333. https:\/\/doi.org\/10.1007\/s40262-017-0608-3","journal-title":"Clinical Pharmacokinetics"},{"key":"1982_CR15","doi-asserted-by":"publisher","first-page":"e12001","DOI":"10.1002\/trc2.12001","volume":"6","author":"J Kutzsche","year":"2020","unstructured":"Kutzsche, J., J\u00fcrgens, D., Willuweit, A., Adermann, K., Fuchs, C., Simons, S., Windisch, M., H\u00fcmpel, M., Rossberg, W., Wolzt, M., et al. (2020). Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I study. Alzheimers Dement (N Y), 6, e12001. https:\/\/doi.org\/10.1002\/trc2.12001","journal-title":"Alzheimers Dement (N Y)"},{"key":"1982_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/s1474-4422(08)70167-4","volume":"7","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008). Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as A modifying therapy for alzheimer\u2019s disease: A phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurology, 7, 779\u2013786. https:\/\/doi.org\/10.1016\/s1474-4422(08)70167-4","journal-title":"Lancet Neurology"},{"key":"1982_CR17","doi-asserted-by":"publisher","unstructured":"Scheltens, P., Hallikainen, M., Grimmer, T., Duning, T., Gouw, A. A., Teunissen, C. E., Wink, A. M., Maruff, P., Harrison, J., van Baal, C. M., et al. (2018). Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer\u2019s disease: results of a randomized, double-blind, placebo-controlled phase 2a study. Alzheimer\u2019S Research & Therapy, 10. https:\/\/doi.org\/10.1186\/s13195-018-0431-6","DOI":"10.1186\/s13195-018-0431-6"},{"key":"1982_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.celrep.2017.06.023","volume":"20","author":"LT Haas","year":"2017","unstructured":"Haas, L. T., Salazar, S. V., Smith, L. M., Zhao, H. R., Cox, T. O., Herber, C. S., Degnan, A. P., Balakrishnan, A., Macor, J. E., Albright, C. F., et al. (2017). Silent allosteric modulation of mGluR5 maintains glutamate signaling while rescuing alzheimer\u2019s mouse phenotypes. Cell Rep, 20, 76\u201388. https:\/\/doi.org\/10.1016\/j.celrep.2017.06.023","journal-title":"Cell Rep"},{"key":"1982_CR19","doi-asserted-by":"publisher","first-page":"eabi8593","DOI":"10.1126\/scitranslmed.abi8593","volume":"14","author":"J Spurrier","year":"2022","unstructured":"Spurrier, J., Nicholson, L., Fang, X. T., Stoner, A. J., Toyonaga, T., Holden, D., Siegert, T. R., Laird, W., Allnutt, M. A., Chiasseu, M., et al. (2022). Reversal of synapse loss in alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. Science Translational Medicine, 14, eabi8593. https:\/\/doi.org\/10.1126\/scitranslmed.abi8593","journal-title":"Science Translational Medicine"},{"key":"1982_CR20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/alz.12302","volume":"17","author":"NJ Izzo","year":"2021","unstructured":"Izzo, N. J., Yuede, C. M., LaBarbera, K. M., Limegrover, C. S., Rehak, C., Yurko, R., Waybright, L., Look, G., Rishton, G., Safferstein, H., et al. (2021). Preclinical and clinical biomarker studies of CT1812: A novel approach to alzheimer\u2019s disease modification. Alzheimers Dement, 17, 1365\u20131382. https:\/\/doi.org\/10.1002\/alz.12302","journal-title":"Alzheimers Dement"},{"key":"1982_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J., Chiao, P., Bussi\u00e8re, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016). The antibody aducanumab reduces A\u03b2 plaques in alzheimer\u2019s disease. Nature, 537, 50\u201356. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"key":"1982_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2021.3854","volume":"325","author":"GC Alexander","year":"2021","unstructured":"Alexander, G. C., Emerson, S., & Kesselheim, A. S. (2021). Evaluation of aducanumab for alzheimer disease: Scientific evidence and regulatory review involving Efficacy, Safety, and futility. Journal of the American Medical Association, 325, 1717\u20131718. https:\/\/doi.org\/10.1001\/jama.2021.3854","journal-title":"Journal of the American Medical Association"},{"key":"1982_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","volume":"181","author":"B Dunn","year":"2021","unstructured":"Dunn, B., Stein, P., & Cavazzoni, P. (2021). Approval of aducanumab for alzheimer Disease-The fda\u2019s perspective. JAMA Intern Med, 181, 1276\u20131278. https:\/\/doi.org\/10.1001\/jamainternmed.2021.4607","journal-title":"JAMA Intern Med"},{"key":"1982_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A., Lo, A. C., Evans, C. D., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021). Donanemab in early alzheimer\u2019s disease. New England Journal of Medicine, 384, 1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"New England Journal of Medicine"},{"key":"1982_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Dyck","year":"2023","unstructured":"Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023). Lecanemab in early alzheimer\u2019s disease. New England Journal of Medicine, 388, 9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"New England Journal of Medicine"},{"key":"1982_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron, 48, 913\u2013922. https:\/\/doi.org\/10.1016\/j.neuron.2005.10.028","journal-title":"Neuron"},{"key":"1982_CR27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nn.2433","volume":"12","author":"E Abramov","year":"2009","unstructured":"Abramov, E., Dolev, I., Fogel, H., Ciccotosto, G. D., Ruff, E., & Slutsky, I. (2009). Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nature Neuroscience, 12, 1567\u20131576. https:\/\/doi.org\/10.1038\/nn.2433","journal-title":"Nature Neuroscience"},{"key":"1982_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/jad-2009-1230","volume":"19","author":"JE Morley","year":"2010","unstructured":"Morley, J. E., Farr, S. A., Banks, W. A., Johnson, S. N., Yamada, K. A., & Xu, L. (2010). A physiological role for amyloid-beta protein:enhancement of learning and memory. Journal of Alzheimer\u2019S Disease, 19, 441\u2013449. https:\/\/doi.org\/10.3233\/jad-2009-1230","journal-title":"Journal of Alzheimer\u2019S Disease"},{"key":"1982_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fncel.2015.00297","volume":"9","author":"ML Giuffrida","year":"2015","unstructured":"Giuffrida, M. L., Tomasello, M. F., Pandini, G., Caraci, F., Battaglia, G., Busceti, C., Di Pietro, P., Pappalardo, G., Attanasio, F., Chiechio, S., et al. (2015). Monomeric \u00df-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons. Frontiers in Cellular Neuroscience, 9, 297. https:\/\/doi.org\/10.3389\/fncel.2015.00297","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"1982_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/elife.106156.1","author":"I Talucci","year":"2025","unstructured":"Talucci, I., Leske, T., Klafki, H. W., Hassan, M. M., Steiert, A., Morgado, B., Bothe, S., van Werven, L., Liepold, T., Walter, J. (2025). Epitope Sequence and Modification Fingerprints of Anti-A\u03b2 Antibodies. doi:https:\/\/doi.org\/10.7554\/elife.106156.1.","journal-title":"Epitope Sequence and Modification Fingerprints of Anti-A\u03b2 Antibodies"},{"key":"1982_CR31","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1074\/jbc.M109.045187","volume":"285","author":"GS Basi","year":"2010","unstructured":"Basi, G. S., Feinberg, H., Oshidari, F., Anderson, J., Barbour, R., Baker, J., Comery, T. A., Diep, L., Gill, D., Johnson-Wood, K., et al. (2010). Structural correlates of antibodies associated with acute reversal of amyloid \u03b2-related behavioral deficits in a mouse model of alzheimer disease. Journal of Biological Chemistry, 285, 3417\u20133427. https:\/\/doi.org\/10.1074\/jbc.M109.045187","journal-title":"Journal of Biological Chemistry"},{"key":"1982_CR32","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1074\/jbc.RA120.015501","volume":"296","author":"JM Reyes-Ruiz","year":"2021","unstructured":"Reyes-Ruiz, J. M., Nakajima, R., Baghallab, I., Goldschmidt, L., Sosna, J., Mai Ho, P. N., Kumosani, T., Felgner, P. L., & Glabe, C. (2021). An epitomic analysis of the specificity of conformation-dependent, anti-A\u00df amyloid monoclonal antibodies. Journal of Biological Chemistry, 296, 100168. https:\/\/doi.org\/10.1074\/jbc.RA120.015501","journal-title":"Journal of Biological Chemistry"},{"key":"1982_CR33","doi-asserted-by":"publisher","unstructured":"Bittrich, S., Segura, J., Duarte, J. M., Burley, S. K., & Rose, Y. (2024). RCSB protein data bank: Exploring protein 3D similarities via comprehensive structural alignments. Bioinformatics, 40. https:\/\/doi.org\/10.1093\/bioinformatics\/btae370","DOI":"10.1093\/bioinformatics\/btae370"},{"key":"1982_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J., Adler, J., Dunger, J., Evans, R., Green, T., Pritzel, A., Ronneberger, O., Willmore, L., Ballard, A. J., Bambrick, J., et al. (2024). Accurate structure prediction of biomolecular interactions with alphafold 3. Nature, 630, 493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w","journal-title":"Nature"},{"key":"1982_CR35","doi-asserted-by":"publisher","unstructured":"Villanueva, R. A. M., & Chen, Z. J. (2019). ggplot2: Elegant Graphics for Data Analysis, 2nd edition. Measurement-Interdisciplinary Research and Perspectives 17, 160\u2013167. https:\/\/doi.org\/10.1080\/15366367.2019.1565254","DOI":"10.1080\/15366367.2019.1565254"},{"key":"1982_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2307\/3001913","volume":"5","author":"JW Tukey","year":"1949","unstructured":"Tukey, J. W. (1949). Comparing individual means in the analysis of variance. Biometrics, 5, 99\u2013114.","journal-title":"Biometrics"},{"key":"1982_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W","volume":"19","author":"R Fraczkiewicz","year":"1998","unstructured":"Fraczkiewicz, R., & Braun, W. (1998). Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. Journal of Computational Chemistry, 19, 319\u2013333. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199802)19:3%3C319::AID-JCC6%3E3.0.CO;2-W","journal-title":"Journal of Computational Chemistry"},{"key":"1982_CR38","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molp.2020.06.009","volume":"13","author":"C Chen","year":"2020","unstructured":"Chen, C., Chen, H., Zhang, Y., Thomas, H. R., Frank, M. H., He, Y., & Xia, R. (2020). TBtools: An integrative toolkit developed for interactive analyses of big biological data. Molecular Plant, 13, 1194\u20131202. https:\/\/doi.org\/10.1016\/j.molp.2020.06.009","journal-title":"Molecular Plant"},{"key":"1982_CR39","doi-asserted-by":"publisher","first-page":"1322712","DOI":"10.3389\/fimmu.2024.1322712","volume":"15","author":"MH H\u00f8ie","year":"2024","unstructured":"H\u00f8ie, M. H., Gade, F. S., Johansen, J. M., W\u00fcrtzen, C., Winther, O., Nielsen, M., & Marcatili, P. (2024). DiscoTope-3.0: Improved B-cell epitope prediction using inverse folding latent representations. Frontiers in Immunology, 15, 1322712. https:\/\/doi.org\/10.3389\/fimmu.2024.1322712","journal-title":"Frontiers in Immunology"},{"key":"1982_CR40","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","volume":"30","author":"K Katoh","year":"2002","unstructured":"Katoh, K., Misawa, K., Kuma, K., & Miyata, T. (2002). MAFFT: A novel method for rapid multiple sequence alignment based on fast fourier transform. Nucleic Acids Research, 30, 3059\u20133066. https:\/\/doi.org\/10.1093\/nar\/gkf436","journal-title":"Nucleic Acids Research"},{"key":"1982_CR41","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009). Jalview version 2\u2014a multiple sequence alignment editor and analysis workbench. Bioinformatics, 25, 1189\u20131191. https:\/\/doi.org\/10.1093\/bioinformatics\/btp033","journal-title":"Bioinformatics"},{"key":"1982_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41592-025-02593-7","volume":"22","author":"W Kim","year":"2025","unstructured":"Kim, W., Mirdita, M., Levy Karin, E., Gilchrist, C. L. M., Schweke, H., S\u00f6ding, J., Levy, E. D., & Steinegger, M. (2025). Rapid and sensitive protein complex alignment with Foldseek-Multimer. Nature Methods, 22, 469\u2013472. https:\/\/doi.org\/10.1038\/s41592-025-02593-7","journal-title":"Nature Methods"},{"key":"1982_CR43","doi-asserted-by":"publisher","unstructured":"Abraham, M. J., Murtola, T., Schulz, R., P\u00e1ll, S., Smith, J. C., Hess, B., & Lindahl, E. G. R. O. M. A. C. S. High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015, 1\u20132, 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"1982_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/biotech14030073","volume":"14","author":"K Jung","year":"2025","unstructured":"Jung, K., Jo, I., Choi, B. Y., & Kim, J. (2025). Structure-Based pipeline for plant enzymes: Pilot study identifying novel ginsenoside biosynthetic UGTs. BioTech, 14, 73.","journal-title":"BioTech"},{"key":"1982_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/abt\/tbae007","volume":"7","author":"WR Strohl","year":"2024","unstructured":"Strohl, W. R. (2024). Structure and function of therapeutic antibodies approved by the US FDA in 2023. Antibody Therapeutics, 7, 132\u2013156. https:\/\/doi.org\/10.1093\/abt\/tbae007","journal-title":"Antibody Therapeutics"},{"key":"1982_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/bioengineering11010045","volume":"11","author":"KL Nystuen","year":"2024","unstructured":"Nystuen, K. L., McNamee, S. M., Akula, M., Holton, K. M., DeAngelis, M. M., & Haider, N. B. (2024). Alzheimer\u2019s disease: Models and molecular mechanisms informing disease and treatments. Bioengineering, 11, 45.","journal-title":"Bioengineering"},{"key":"1982_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang, J., Kong, G., Yang, J., Pang, L., & Li, X. (2025). Pathological mechanisms and treatment progression of alzheimer\u2019s disease. European Journal of Medical Research, 30, 625. https:\/\/doi.org\/10.1186\/s40001-025-02886-9","journal-title":"European Journal of Medical Research"},{"key":"1982_CR48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. (2014). Amyloid-\u03b2 and tau: The trigger and bullet in alzheimer disease pathogenesis. JAMA Neurology, 71, 505\u2013508. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurology"},{"key":"1982_CR49","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh, Z., & Karaman, R. (2020). Comprehensive review on alzheimer\u2019s disease: Causes and treatment. Molecules, 25, 5789.","journal-title":"Molecules"},{"key":"1982_CR50","doi-asserted-by":"publisher","unstructured":"Cao, Y., Zhao, L. W., Chen, Z. X., & Li, S. H. (2024). New insights in lipid metabolism: Potential therapeutic targets for the treatment of alzheimer\u2019s disease. Frontiers in Neuroscience, 18 (2024). https:\/\/doi.org\/10.3389\/fnins.2024.1430465","DOI":"10.3389\/fnins.2024.1430465"},{"key":"1982_CR51","doi-asserted-by":"publisher","unstructured":"D\u2019Alonzo, Z. J., Lam, V., Takechi, R., Nesbit, M., Vaccarezza, M., & Mamo, J. C. L. (2023). Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for alzheimer\u2019s disease: Potential interactive effects of APOE genotype with dietary fats. Genes & Nutrition, 18(2). https:\/\/doi.org\/10.1186\/s12263-023-00722-5","DOI":"10.1186\/s12263-023-00722-5"},{"key":"1982_CR52","doi-asserted-by":"publisher","first-page":"8726","DOI":"10.3390\/ijms26178726","volume":"26","author":"W Grabowska","year":"2025","unstructured":"Grabowska, W., Bijak, M., Szelenberger, R., Gorniak, L., Podogrocki, M., Harmata, P., & Cichon, N. (2025). Acetylcholinesterase as a multifunctional target in Amyloid-Driven neurodegeneration: From Dual-Site inhibitors to Anti-Agregation strategies. International Journal of Molecular Sciences, 26, 8726.","journal-title":"International Journal of Molecular Sciences"},{"key":"1982_CR53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12668-016-0375-x","volume":"7","author":"SV Lushchekina","year":"2017","unstructured":"Lushchekina, S. V., Kots, E. D., Novichkova, D. A., Petrov, K. A., & Masson, P. (2017). Role of acetylcholinesterase in \u03b2-Amyloid aggregation studied by accelerated molecular dynamics. BioNanoScience, 7, 396\u2013402. https:\/\/doi.org\/10.1007\/s12668-016-0375-x","journal-title":"BioNanoScience"},{"key":"1982_CR54","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/ijms25063401","volume":"25","author":"J Batko","year":"2024","unstructured":"Batko, J., Antosz, K., Mi\u015bk\u00f3w, W., Pszczo\u0142owska, M., Walczak, K., & Leszek, J. (2024). Chaperones\u2014A new class of potential therapeutic targets in alzheimer\u2019s disease. International Journal of Molecular Sciences, 25, 3401.","journal-title":"International Journal of Molecular Sciences"},{"key":"1982_CR55","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3390\/diagnostics12122981","volume":"12","author":"AF Prawiningrum","year":"2022","unstructured":"Prawiningrum, A. F., Paramita, R. I., & Panigoro, S. S. (2022). Immunoinformatics approach for Epitope-Based vaccine design: Key steps for breast cancer vaccine. Diagnostics, 12, 2981.","journal-title":"Diagnostics"},{"key":"1982_CR56","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.csbj.2025.05.039","volume":"27","author":"J Guan","year":"2025","unstructured":"Guan, J., Xie, P., Meng, D., Yao, L., Yu, D., Chiang, Y. C., Lee, T. Y., Wang, J., & ToxiPep (2025). Peptide toxicity prediction via fusion of context-aware representation and atomic-level graph. Computational and Structural Biotechnology Journal, 27, 2347\u20132358. https:\/\/doi.org\/10.1016\/j.csbj.2025.05.039","journal-title":"Computational and Structural Biotechnology Journal"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01982-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:23:25Z","timestamp":1780482205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01982-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1982"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01982-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"21 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}